[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352641-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352641-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","baicalin-augments-5-fluorouracil-efficacy-in-colorectal-cancer-by-triggering-mlkl-dependent-necroptosis-a-novel-strategy-to-overcome-chemoresistance","Baicalin Augments 5-Fluorouracil Efficacy in Colorectal Cancer by Triggering MLKL-Dependent Necroptosis - A Novel Strategy to Overcome Chemoresistance","","5-Fluorouracil (5-Fu) is a core therapy for colorectal cancer (CRC), yet monotherapy is limited by severe toxicity and chemoresistance. Combining agents is used to improve efficacy and safety, but Baicalin’s role in CRC chemosensitization—especially against 5-Fu resistance—remains insufficiently defined. This study evaluates Baicalin plus 5-Fu using in vitro assays and an in vivo xenograft model. Mechanisms are analyzed by Western blot, qPCR, and RNA-seq, showing MLKL-dependent necroptosis activation and enhanced 5-Fu cytotoxicity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/baicalin-augments-5-fluorouracil-efficacy-in-colorectal-cancer-by-triggering-mlkl-dependent-necroptosis-a-novel-strategy-to-overcome-chemoresistance/352641/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/baicalin-augments-5-fluorouracil-efficacy-in-colorectal-cancer-by-triggering-mlkl-dependent-necroptosis-a-novel-strategy-to-overcome-chemoresistance/352641.png","ImageObject",300,407,{"name":42,"@type":43},"Connor ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is 5-fluorouracil limited in colorectal cancer therapy?","Question",{"text":63,"@type":64},"5-Fu monotherapy is hindered by dose-limiting toxicities and the frequent emergence of chemoresistance, which reduce treatment effectiveness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the rationale for combining Baicalin with 5-fluorouracil?",{"text":68,"@type":64},"Baicalin is presented as a multi-target natural compound with anti-tumor potential, and the study aims to determine whether it can enhance 5-Fu’s efficacy and help overcome 5-Fu resistance in CRC.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism is reported for Baicalin-enhanced 5-Fu cytotoxicity?",{"text":72,"@type":64},"Baicalin enhances 5-Fu cytotoxicity by activating the MLKL-dependent necroptosis pathway, supported by functional assays and molecular analyses.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352641,1790175600,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nBaicalin Augments 5-Fluorouracil Efficacy in Colorectal Cancer by Triggering MLKL-Dependent Necroptosis: A Novel Strategy to Overcome Chemoresistance  \nJingwen Yuan †, Zhiying Peng †, Rongbo Wen, Leqi Zhou, Fuao Cao, Tianshuai Zhang, Yingjie Wu, Jiayue Wu, Ran Lin, Guanyu Yu * and Wei Zhang *  \nAcademic Editor: Carmine Stolfi  \nReceived: 2 February 2026  \nRevised: 15 March 2026  \nAccepted: 20 March 2026  \nPublished: 23 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nColorectal Surgery Department, Changhai Hospital, Naval Medical University, Shanghai 200433, China;  \n[yuanjingwen718@whu.edu.cn](yuanjingwen718@whu.edu.cn) (J.Y.); [p1zy24@163.com](p1zy24@163.com) (Z.P.); [wrb1213@hotmail.com](wrb1213@hotmail.com) (R.W.);  \n[richard12@126.com](richard12@126.com) (L.Z.); [caofuao@163.com](caofuao@163.com) (F.C.); [zhangtianshuai0106@163.com](zhangtianshuai0106@163.com) (T.Z.);  \n[smmuwyj@163.com](smmuwyj@163.com) (Y.W.); [wujiayue03@163.com](wujiayue03@163.com) (J.W.); [linr278@163.com](linr278@163.com) (R.L.)  \n* [Correspondence: yuguanyu0451@smmu.edu.cn](Correspondence: yuguanyu0451@smmu.edu.cn) (G.Y.); [weizhang2000cn@163.com](weizhang2000cn@163.com) (W.Z.)† These authors contributed equally to this work.  \nAbstract  \n5-Fluorouracil (5-Fu) remains essential in colorectal cancer (CRC) treatment, but monotherapy causes severe toxicity and faces chemoresistance. Combination regimens are encouraged to improve efficacy and safety. Natural compounds like Baicalin show anti-tumor potential in other gastrointestinal cancers, yet their role in CRC, particularly in overcoming 5-Fu resistance, is underexplored. The combined effect of Baicalin and 5-Fu was evaluated through in vitro functional assays and an in vivo xenograft model. Mechanisms were investigated using Western blot, qPCR, and RNA-seq. Baicalin enhanced 5-Fu to inhibit CRC progression both in vitro and in vivo. Mechanistically, Baicalin enhanced 5-Fu cytotoxicity by activating the MLKL-dependent necroptosis pathway. This study proposes the Baicalin and 5-Fu combination as a novel and potent chemosensitizing strategy for CRC, especially in 5-Fu-resistant cases, and provides a mechanistic rationale for Baicalin asa chemotherapy-enhancing agent.  \nKeywords: baicalin; 5-fluorouracil; colorectal cancer; necroptosis; chemoresistance  \n1. Introduction  \nColorectal cancer (CRC) remains a significant global health issue, being the third most frequently diagnosed cancer and the second highest cause of cancer-related mortality worldwide [1] . According to recent global cancer burden data, there were over 1.9 million new CRC cases and nearly 935,000 deaths in 2020, with incidence rates rising in rapidly developing countries. This alarming epidemiological trend underscores the urgent need for innovative therapeutic advancements. While surgical resection offers a potential cure for localized tumors, systemic chemotherapy serves as the cornerstone of treatment for patients with advanced or metastatic CRC, among whom the five-year survival rate remains dishearteningly low [2] . Currently, for metastatic CRC (mCRC), standard-of-care treatment has evolved to include combination regimens such as FOLFOX (5-Fu + Oxaliplatin) or FOLFIRI (5-Fu + Irinotecan), often in conjunction with targeted therapies like bevacizumab (anti-VEGF) or cetuximab (anti-EGFR) for select patient populations [3,4] . However, the efficacy of these regimens is ultimately limited by both primary and acquired resistance, highlighting the persistent need for novel, well-tolerated sensitizing agents.  \n5-fluorouracil (5-Fu), a fluoropyrimidine analog, has been a fundamental component of CRC chemotherapy for more than fifty years. Its primary mechanism of action involves inhibiting thymidylate synthase and incorporating it into RNA and DNA, thereby dis","cbCaifUEBmR2zoNr","https://ap.wps.com/l/cbCaifUEBmR2zoNr","pdf",4336007,18,"English","# Introduction\n## 5-Fluorouracil in colorectal cancer: mechanisms and limitations\n## Chemoresistance and the need for chemosensitizers","[{\"question\":\"Why is 5-fluorouracil limited in colorectal cancer therapy?\",\"answer\":\"5-Fu monotherapy is hindered by dose-limiting toxicities and the frequent emergence of chemoresistance, which reduce treatment effectiveness.\"},{\"question\":\"What is the rationale for combining Baicalin with 5-fluorouracil?\",\"answer\":\"Baicalin is presented as a multi-target natural compound with anti-tumor potential, and the study aims to determine whether it can enhance 5-Fu’s efficacy and help overcome 5-Fu resistance in CRC.\"},{\"question\":\"What mechanism is reported for Baicalin-enhanced 5-Fu cytotoxicity?\",\"answer\":\"Baicalin enhances 5-Fu cytotoxicity by activating the MLKL-dependent necroptosis pathway, supported by functional assays and molecular analyses.\"}]","Baicalin Augments 5-Fluorouracil Efficacy in Colorectal Cancer by Triggering MLKL-Dependent Necroptosis - A Novel Strategy to Overcome Chemoresistance | PDF",1790100593,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f54b30adeb7bb58da600507b509e7a7.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e51f992b78f7a3ae04ca1cabacf27783.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5429fcf7bf9a3af4026c124dbd99fbfa.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/353a96641d0133c4d6118683d8453e0d.webp",980,1385]